Blanket refusals of coverage remain common at national and subnational levels, which is unethical
What we did To better understand this emerging pattern, Mira conducted a survey of 310 women who use the Mira hormone monitor and were using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Zepbound, and others
The durability difference reflects GLP-1's action on multiple metabolic pathways rather than relying on acute sympathetic nervous system activation alone
About 12,000 people starting GLP-1 drugs were compared against roughly 15,200 starting SGLT-2 inhibitors, and a separate group of about 12,000 GLP-1 starters was compared against 11,233 starting DPP-4 inhibitors
These statements are based on managements current expectations, but actual results may differ materially due to various factors